Ðe Peripheral T-cell Lymphoma (PTCL) le ŋuwòa? Mègatsi dzi o, mina míaƒo nu tso eŋu!

Ɣeaɖewoɣi la, míate ŋu axɔ dɔléle siwo ŋu míebuna gɔ̃ hã o, alo? Peripheral T-cell Lymphoma, alo PTCL kpuie, nye dɔléle si sesẽ vie, gake ele vevie ŋutɔ be nànyae. Menye dɔléle ɖeka ŋutɔŋutɔe wònye o, ke boŋ dɔléle geɖe ƒe ƒuƒoƒoe. Ðe míaƒo nu tso esia ŋu bɔbɔe, le mɔ si gɔme nàse nua?

Le nyateƒe me la, menye dɔléle ɖeka koe peripheral T-cell Lymphoma (PTCL) nye o. Enye ʋumenugbagbeviɣidɔ ƒomevi vovovo siwo nu sẽ ŋutɔ ƒe ƒuƒoƒo. Etɔxɛe la, ekpɔa ŋusẽ ɖe míaƒe ʋukawo ƒe dɔwɔwɔ dzi . Ðewohĩ èse be ``Non-Hodgkin lymphoma'', eye nenemae wòle. Nu ɖeka si le PTCL ŋue nye be ate ŋu akaka (akaka) tso ŋutilã ƒe akpa ɖeka ayi akpa bubuwo . Esia fia be ate ŋu adze ŋutilã ƒe akpa ɖesiaɖe kloe, eyata dzesiawo ate ŋu ato vovo.

Nya nyuiae nye be ɖɔktawo ate ŋu aɖu PTCL ƒe ƒomevi sue geɖe dzi dzidzedzetɔe. Gake ɣeaɖewoɣi la, dɔlélea ate ŋu agadzɔ ake . Esia tae atikewɔwɔ ŋuti numekulawo le atike yeye siwo ate ŋu akpe ɖe amewo ŋu woanɔ agbe didi kple PTCL dim ɣesiaɣi ɖo.

Ðe dɔléle sia si woyɔna be PTCL bɔa?

Ao, le nyateƒe me la, esia menye dɔléle si bɔ ŋutɔ o . Numekuku aɖe si wowɔ le xexeame katã ɖee fia be ame siwo ade akpe alafa eve xɔa PTCL. Ame siwo xɔa `(Non-Hodgkin lymphoma)` la dometɔ siwo ade 10% xɔ PTCL.

Wokpɔa nɔnɔme sia zi geɖe vie le míaƒe Asia-dukɔwo, Afrika, kple Caribbean-ƒukpowo dzi wu United States. Zi geɖe la, edzea ame siwo xɔ wu ƒe 60. Gake ƒomevi aɖewo ate ŋu adze ɖe ɖevi suewo kple sɔhɛ tsitsiwo hã dzi .

Nukawoe nye PTCL ƒomevi veviwo?

Xexeame ƒe Lãmesẽ Habɔbɔ (WHO) de dzesi PTCL ƒe ƒomevi sue siwo wu 20. Domenyiŋusẽfianu tɔxɛ aɖewo le amesiawo dometɔ ɖesiaɖe si. Mina míalé ŋku ɖe ƒomevi siwo bɔ wu dometɔ aɖewo ŋu.

Peripheral T-cell lymphoma, si womegblɔe bubui o (PTCL-NOS) .

Esiae nye ƒomevi sue si bɔ wu . ``(PTCL-NOS)`` nye hatsotso si me nya siwo womateŋu aɖe nyuie o eye womesɔ ɖe ƒomevi sue bubu siwo me kɔ la me o. PTCL dɔnɔwo katã ƒe 30% lɔƒo dzena le hatsotso sia me. Ate ŋu agblẽ nu le wò ʋukawo , ƒumeŋuɖui , dɔgbo , alo aklã koŋ ŋu.

Angioimmunoblastic T-cell lymphoma (AITL) ƒe ʋumenugbagbeviɣidɔ .

Esia dzɔna le PTCL dɔnɔwo ƒe 15% va ɖo 30% hã me le xexeame katã. AITL ate ŋu akpɔ ŋusẽ ɖe wò dɔgbo, ƒumeŋuɖui, dɔgbo, alo aklã hã dzi.

Anaplastic lãmenugbagbevi gãwo ƒe ʋumenugbagbeviɣidɔ (ALCL) .

`(ALCL)` ƒe nɔnɔme vovovowo hã li.

• Ðeka li si woyɔna be primary cutaneous ALCL , si gblẽa nu le ŋutigbalẽa ŋu .
• Ðeka gali hã.Systemic ALCL, si gblẽa nu le lãkusi, ŋutigbalẽ, kple ŋutinu bubuwo ŋu. Ɣeaɖewoɣi la, wogadea ALCL sia si le ɖoɖo nu la hatsotsowo me ɖe tɔtrɔ siwo va le domenyiŋusẽfianu aɖe koŋ si woyɔna be ALK (anaplastic lymphoma kinase) me dzi . PTCL ƒe 15% lɔƒo dzena ɖe ``(ALCL)`` ƒomevi sia me.

Extranodal dzɔdzɔmewu/T-lãmenugbagbeviwo ƒe ʋumenugbagbeviɣidɔ, no me ƒomevi

Esia nye etɔxɛ vie. Zi geɖe la , ƒomevi sue sia dona le wò ŋɔti ƒe lãkusiwo , ʋuka siwo me ʋu sina tona , kple ŋɔti ƒe akpa si le etame . Gake ate ŋu akaka ɖe ŋutigbalẽ, nuɖuɖumeŋusẽ , kple ŋutinu bubuwo me ɣeaɖewoɣi. Esia ƒomevi nye PTCL ƒe 10% lɔƒo.

Dɔgbo me T-lãmenugbagbeviwo ƒe ʋumenugbagbeviɣidɔ

Ŋkɔa ɖee fia be ele nenema, alo? Esia gblẽa nu le nuɖuɖumeŋusẽ ŋu . Exɔa PTCL ƒe 6% lɔƒo. Ƒomevi siwo woyɔna be enteropathy-associated T-cell lymphoma (EATL) kple monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) hã le esi .

Ame tsitsiwo ƒe T-lãmenugbagbeviwo ƒe ʋumenugbagbeviɣidɔ/ʋumenugbagbeviɣidɔ (ATLL) .

Ate ŋu agblẽ nu le ŋutigbalẽ kple ƒuwo ŋu. ATLL ƒe hatsotso sue enee li: dɔléle sesẽ, ʋumenugbagbeviɣidɔ, dɔléle si nɔa anyi didi, kple dzudzɔxɔxɔledɔme . Dɔlékui ƒomevi eve siwo bɔ wue nye acute kple lymphoma, siwo nyea adãwɔwɔ. Atike ƒomevi siwo nɔa anyi didi kple esiwo le dzudzɔ tum la tsina blewu wu . ATLL ƒe ƒomevi sue ɖesiaɖe gblẽa nu le ŋutilã ƒe akpa vovovowo ŋu.

Nukae nye PTCL ƒe dzesiwo?

Togbɔ be dzesi aɖewo koŋ le PTCL ƒe hatsotso sue ɖesiaɖe ŋu hã la, ɖewo li siwo bɔ. Mina míalé ŋku ɖe nusiwo wonye ŋu:

• Lãmetsiŋusẽ siwo vuvu: Àte ŋu avuvu le wò kɔ, abɔta, alo akɔta si me vevesese aɖeke mele o . Kpɔe ɖa le susu me be ƒu sue aɖe le wò kɔ me si se le ɖokuiwò me abe ɖe wòle lolom ɖe edzi le ɣeyiɣi aɖe megbe ene, gake mevea ame o. Emae nye ema.
• Lolo dzi ɖeɖe kpɔtɔ si womeɖe o: Ne èɖe wò kpekpeme bliboa ƒe 10% lɔƒo le ɣleti ade me, evɔ mèdze agbagba vevie o la, enye nusi ŋu wòle be nàtsi dzi ɖo.
• Ƒodo ƒe vevesese alo vuvu: Esia ate ŋu adzɔ ne wò dɔgbo lolo. Ðewohĩ màvo le ɖokuiwò me o, abe ɖe wò dɔgbo yɔ ene.
• Ðeɖiteameŋu si nɔa anyi ɖaa: Ðeɖiteameŋu ƒe seselelãme si mebɔ o ŋkeke geɖe susu aɖeke manɔmee. Ðeko wòle abe ɖe ɖeɖiteameŋua nu yina aleke kee nèdɔ alɔ̃ o ene.
• Asrã si womeɖe o: Zi geɖe la, asrã dzɔna ne ŋutilãa le avu wɔm kple dɔlékui aɖe. Gake ne asrã si ƒe dzoxɔxɔ wu Celsius 39.5 (Fahrenheit 103) yi edzi wu gaƒoƒo eve le aƒeme atikewɔwɔ vɔ megbe, alo ne asrãa yi edzi wu ŋkeke eve la, ate ŋu anye nane si nu sẽ wu ƒe dzesi.

Nu vevitɔe nye be mehiã be nàtsi dzi ɖe PTCL xɔxɔ ŋu le esi dzesi siawo le ŋuwò ta ko o. Woate ŋu atso nu bubu siwo le bɔbɔe wu gbɔ. Gake ne dzesi siawo gakpɔtɔ li la, .Ele vevie ŋutɔ be nàkpɔ ɖɔkta godoo ahaxɔ aɖaŋuɖoɖo.

Azɔ mina míakpɔ dzesi siwo va kpe ɖe ƒomevi sue aɖewo koŋ ŋu ɖa.

Nu bubu siwo dzena le peripheral T-cell lymphoma ŋu, si womegblɔe bubui o (PTCL-NOS) .

Tsɔ kpe ɖe dzesi siwo bɔ ŋu la, àte ŋu akpɔe hã be:

• Ʋumenugbagbevi dzĩwo ƒe ɖiɖi (Ʋusɔgbɔdɔ) - Esia ate ŋu ana ame nazu ɣie eye ɖeɖi nadzi ɖe edzi.
• Ʋumenugbagbeviɣidɔ ƒe agbɔsɔsɔ si bɔbɔ (Thrombocytopenia) - Esia ate ŋu ana ʋu nado le eɖokui me.
• Teƒe dzĩ siwo le ʋuʋum le ŋutigbalẽa ŋu.
• Ne kansa la le akɔta , akɔtave alo gbɔgbɔ sesẽ (gbɔgbɔtsixetsixe).

Nu bubu siwo dzena le ʋumenugbagbeviɣidɔ si woyɔna be angioimmunoblastic T-cell lymphoma (AITL) ŋu

Tsɔ kpe ɖe dzesi siwo bɔ ŋu la:

• Zã me fifia - Fifia ne èle alɔ̃ dɔm ale gbegbe be agbalẽawo tsina.
• Ŋutilã me ʋuʋudedi .
• Dɔlélenutsiŋutete ƒe dɔlélewo abe `(Autoimmune hemolytic anemia) `.

Nu bubu siwo le anaplastic large cell lymphoma (ALCL) ŋu .

Primary cutaneous ALCL (si ƒomevi gblẽa nu le ŋutigbalẽ ŋu) .

• Nuwo abe ŋutigbalẽa ƒe amadede dzĩ alo dzĩ si mebɔ o, ƒunukpeƒetetedɔ siwo lolona ɖe edzi le ɣeyiɣi aɖe megbe ene.
• Ʋuʋudedi siwo le ʋuʋum, gã, siwo le goglo .
• Kpekpe siawo ate ŋu azu abi eye woazu ƒuƒu.

Systemic ALCL (si ƒomevi gblẽa nu le ŋutinu siwo le ememe ŋu) .

Le go sia me la, wokpɔa dzesi siwo bɔ ɖe PTCL me.

Extranodal dzɔdzɔmewu/T-lãmenugbagbeviwo ƒe ʋumenugbagbeviɣidɔ, no me ƒomevi

• No me ʋuʋu, seselelãme abe ɖe ŋɔti xe ene.
• Ʋu si dona le ŋɔti me .
• No ƒe eme va zua ƒuƒuiƒe .
• Mo ƒe vuvu si me vevesese le .
• Ŋku ƒe kuxiwo abe tsi si dona le ŋkuwo me kple ŋku ƒe vevesese ene.

Ame tsitsiwo ƒe T-lãmenugbagbeviwo ƒe ʋumenugbagbeviɣidɔ/ʋumenugbagbeviɣidɔ (ATLL) .

PTCL ƒe dzesiwo bɔ ɖe ATLL ƒe hatsotso sue eneawo katã me.

Nukawoe hea PTCL vɛ?

Kpuie ko la, Peripheral T-cell lymphoma dzɔna ne T lãmenugbagbevi siwo le míaƒe ŋutilã me trɔ (`(mutate)`) wozu kansa lãmenugbagbeviwo. Abe alesi nènyae ene la, T lãmenugbagbevi siawo nye ʋumenugbagbevi ɣi ƒomevi aɖe si kpɔa mía ta tso amedzidzelawo abe dɔlékui siwo gena ɖe míaƒe ŋutilã me ene me. Eyata ne T lãmenugbagbevi siawo trɔ la, wozua kansa lãmenugbagbeviwo eye wodzea dzidziɖedzi gɔme le mɔ si dzi womate ŋu aɖu o nu . Ne wodzi ɖe edzi alea la, woƒoa ƒu ɖe míaƒe lãkusi, dɔgbo, aklã, kple ŋutinu bubuwo me eye wowɔa kansadɔlékuiwo .

Eŋutinunyalawo mekpɔ ke ɖe susu si tae T-lãmenugbagbevi siawo trɔna alea ŋu godoo haɖe o.Gake numekukuwo ɖee fia be edo ƒome kple atikewɔwɔ ƒe nɔnɔme aɖewo.

Le kpɔɖeŋu me:

• Xexeame katã ƒe numekuku aɖe ɖee fia be amesiwo ŋu dɔléle aɖe si woyɔna be celiac dɔléle le ate ŋu axɔ PTCL ƒomevi geɖe, siwo dome ALCL hã le, adzi ɖe edzi.
• Azɔ hã, afɔku ate ŋu anɔ amesiwo ŋu Epstein-Barr dɔlékuia le be woaxɔ extranodal natural killer/T-cell lymphoma.
• Ame siwo ŋu dɔlékui `(Human T-cell lymphotropic virus Type 1 (HTLV-1))` le la le afɔku me be woaxɔ `(acute T-cell lymphoma/leukemia)`.

Aleke wowɔa dea dzesi PTCL?

Ðewohĩ ahiã be ɖɔktawo nawɔ dodokpɔ vovovo geɖe be woake ɖe PTCL ƒomevi tɔxɛ si le wò lãmesẽkuxiwo hem vɛ ŋu. Esiawo ate ŋu anye ʋudodokpɔ, nɔnɔmetatawo dodokpɔ, lãmenugbagbeviwo ƒe dodokpɔ, kple domenyiŋusẽfianu dodokpɔ be woatsɔ asrɔ̃ nu tso domenyiŋusẽfianu si le kansadɔlékuiawo me ŋu.

Ʋudodokpɔwo

Ðɔktawo doa ʋu kpɔ be dɔlékui siwo ate ŋu ado ƒome kple PTCL hã. Esiawo ate ŋu anye:

• Ʋu ƒe xexlẽme bliboa (CBC) .
• Nusiwo wotsɔ ɖɔa lãmenugbagbeviwoe ƒe ƒuƒoƒo si me kɔ (CMP) .
• Lactate dehydrogenase (LDH) dodokpɔ
• Aklãdɔléle B kple Aklãdɔléle C dodokpɔwo
• Amegbetɔ ƒe dɔlélenutsiŋutete ƒe dɔlékui (HIV) dodokpɔ
• Amegbetɔ ƒe T-lãmenugbagbeviwo ƒe ʋumenugbagbeviɣidɔlékui Ƒomevi 1 (HTLV-Ƒomevi 1) dodokpɔwo

Nɔnɔmetatawo ɖeɖe ƒe dodokpɔwo

Scan siawo nana ɖɔktawo kpɔa nyatakaka tso wò ŋutilã ƒe akpa si le eme ŋu, vevietɔ afisi kansa ƒe ƒunukpeƒewo le.

• Kɔmpiuta tomography (CT) ƒe fotoɖeɖe
• Positron emission tomography (PET) ƒe fotoɖeɖe
• Magnetic resonance imaging (MRI) ƒe fotoɖeɖefia

Nu gbagbewo ƒe ŋutilã ƒe akpa aɖewo ɖeɖeɖa

Esia bia be woaɖe lãkusi sue aɖe tso teƒe si ŋu ɖikeke le eye woadoe kpɔ le nusuekpɔmɔ̃ me. Esiae nye mɔ vevitɔ si dzi woato aɖo kpe dɔlélea dzi godoo .

• Lãmetsiŋusẽ ƒe dɔwɔwɔ ŋuti numekuku
• Ŋutilã ƒe lãmenugbagbeviwo ƒe dɔwɔwɔ
• Ƒumeŋuɖui ŋuti numekuku

Nukawoe nye PTCL ƒe afɔɖeɖewo?

Ðɔktawo zãa kansa ƒe afɔɖeɖewo tsɔ wɔa ɖoɖo ɖe atikewɔwɔ ŋu eye wonaa nusi nàte ŋu akpɔ mɔ na tso atikewɔwɔ me (nyagblɔɖi). PTCL ƒe ƒomevi kple afisi kansa ƒe T-lãmenugbagbeviwo kaka ɖoe dea dzesi afɔɖeɖe sia. PTCL ƒe akpa vevi eneawoe nye esi:

• Afɔɖeɖe I: Lãmenugbagbevi ɖeka alo lãmenugbagbeviwo ƒe hatsotso ɖeka me koe T-lãmenugbagbevi siwo ŋu kansa le la le.
• Afɔɖeɖe II: Kansa la gblẽ nu le ʋuka eve alo esi wu nenema ŋu le wò ŋutilã ƒe akpa ɖeka (le kpɔɖeŋu me, le wò kɔ ƒe akpa eveawo, alo le akpa ɖeka dzi le akɔtaƒua tame alo ete).
• Afɔɖeɖe III: Kansa la kaka ɖe lãkusi siwo le wò akɔta ƒe akpa si le etame kple ete la me.
• Akpa IV: Tsɔ kpe ɖe vidzidɔa ŋu la, kansa la gblẽ nu le ŋutinu bubuwo hã ŋu, abe lãkusi, aklã, ƒumeŋuɖui, alo nuɖuɖumeŋusẽ ene.

Nukawoe nye atike siwo wozãna na PTCL?

Esi wònye be PTCL ƒe hatsotso sue geɖe kple afisi kansa la le ta la, atikewɔwɔ ɖeka aɖeke meli si sɔ na amesiame o . Atikewɔwɔ ƒe tiatia ate ŋu ato vovo tso ame ɖeka gbɔ yi bubu gbɔ. Wò ɖɔktae atso nya me le atike nyuitɔ kekeake si nàzã ŋu. Dɔdamɔnu siwo bɔ wu dometɔ aɖewoe nye esi:

• Chemotherapy: Atike vovovo siwo wozãna tsɔ daa dɔe ƒe ƒuƒoƒo. Esiae nye atike vevitɔ si wozãna wu.
• Kekeli ƒe dɔdamɔnu: Wozãa esia kpe ɖe atikewɔmɔnu ŋu ɣeaɖewoɣi, vevietɔ ne kansa la le teƒe ɖeka.
• Atikewɔwɔ si woɖo taɖodzinu na: Esia nye atikewɔwɔ si tɔa ŋku domenyiŋusẽfianu ƒe tɔtrɔ tɔxɛwo (nutations) siwo nana lãmenugbagbevi siwo le lãmesẽ me zua kansa lãmenugbagbeviwo. Esia to vovo na atikewɔmɔnu si wozãna tsã.
• Atikewɔwɔ kple allogeneic stem cell transplantation: Woate ŋu azã atikewɔwɔ sia na PTCL si mewɔa dɔ ɖe atikewɔmɔnu kple keklẽŋusẽdɔdamɔnu dzi o, alo si gadzɔna le atikewɔwɔ vɔ megbe. Esia nye atikewɔwɔ si sesẽ vie wu.

Ɣeaɖewoɣi la, àte ŋu akpɔ gome le PTCL ƒe atike yeyewo dodokpɔwo me . Ðo dze kple wò ɖɔkta tso esia ŋu.

Nukawoe nye atikewɔwɔ ƒe nugbegblẽ le ame ŋu zi geɖe?

Kansadɔdamɔnu geɖe ate ŋu ahe nugbegblẽ aɖewo vɛ. Gake menye amesiamee xɔa nugbegblẽ siawo katã o, eye woƒe sesẽme ate ŋu ato vovo. Le kpɔɖeŋu me, atikewɔmɔnu kple keklẽŋusẽdɔdamɔnu ƒe nugbegblẽ le ame ŋu ate ŋu anye:

• Ɖeɖiteameŋu
• Ahɔhɔ̃ me fuɖename si atikewɔmɔnu hena vɛ - ahɔhɔ̃ me fuɖename ƒe seselelãme, ŋkuɖoɖonudzi ƒe bu, kple susu ƒe dɔwɔwɔ sesẽ.
• Aɖuɖɔtoe kple ʋuʋudedi
• Taɖa ƒe ŋeŋe
• Nu me ƒe abiwo
• Dɔlékuiwo xɔxɔ bɔbɔe wu

Mɔ geɖe li fifia siwo dzi nàto aɖu nugbegblẽ siawo dzi, eyata ƒo nu tso ema hã ŋu na wò ɖɔkta.

Nukae nye PTCL ƒe ŋgɔdonya?

Esia nɔ te ɖe PTCL ƒe ƒomevi dzi ŋutɔŋutɔ, afisi kansa la le, wò lãmesẽ bliboa, kple nenye be kansa la le tsɔtsɔke me (``remission``) kple atikewɔwɔ.``Remission`` fia be dzesi aɖeke mele ŋuwò o eye womateŋu akpɔ kansa ƒe dzesi aɖeke le dodokpɔwo me o. Le go aɖewo me la, woate ŋu ada PTCL keŋkeŋ ne wozã atike siwo wozãna ɖaa.

Gake peripheral T-cell lymphoma ƒomevi geɖe ate ŋu atrɔ ava (`(gbugbɔ)`) . Ne edzɔ alea la, àte ŋu ahiã atike bubu alo atike bubu.

Enye nusi sɔ le dzɔdzɔme nu be nàdi be yeanya nusi nàkpɔ mɔ na tso wò atikewɔwɔ me. Wò ɖɔktae nye ame nyuitɔ kekeake si nànya tso wò nɔnɔmea ŋu. Eyata gblɔ nya nɛ faa eye nàto nyateƒe nɛ le nya sia ŋu eye mègavɔ̃ be yeabia nya o.

Ðe woate ŋu axe mɔ ɖe PTCL nua?

Nublanuitɔe la, ao, le alesi míenya nu la, mɔ aɖeke meli si dzi woato axe mɔ ɖe esia nu o . T-lãmenugbagbeviwo ƒe nuwɔna gbegblẽ kple kansa xɔxɔ gbɔe ʋumenugbagbeviɣidɔ sia tsona. Naneke meli míate ŋu awɔ be wòagadzɔ o. Gake ne woƒo asa na afɔku aɖewo (e.g., HTLV-1 dɔlékui) ate ŋu aɖe afɔku si le PTCL ƒomevi siwo do ƒome kplii la xɔxɔ me dzi akpɔtɔ.

Aleke malé be na ɖokuinye? (Agbenɔnɔ kple PTCL)

Peripheral T-cell lymphoma nye kansa ƒomevi aɖe si mebɔ o, si le dzidzim ɖe edzi kabakaba. Ne PTCL le ŋuwò la, aɖaŋuɖoɖo aɖewo siwo akpe ɖe ŋuwò nànɔ agbe ɖe nɔnɔmea nue nye esi:

• Bu beléle si naa ame ƒe dzi dzea eme ŋu: Beléle sia ate ŋu akpe ɖe ŋuwò nàkpɔ dɔlélea ƒe dzesiwo kple atikewɔwɔ ƒe nugbegblẽ le ame ŋu gbɔ. Gawu la, wò dɔlélenutsiŋutete ƒe ƒuƒoƒo ate ŋu ado alɔ wò le seselelãmekuxiwo (blanuiléle, vɔvɔ̃, dzimaɖitsitsi) siwo dona tso agbenɔnɔ kple dɔléle sesẽ sia tɔgbe gbɔ kpɔkpɔ me.
• Di kpekpeɖeŋu: Esi wònye be PTCL nye kansa si mebɔ o ta la, àte ŋu ase le ɖokuiwò me be ye ɖeka koe le ekpɔm. Gake mehiã be wò ɖeka nàyi edzi o. Ƒo nu kple wò atikewɔlawo ƒe ƒuƒoƒo eye nànya nu tso kpekpeɖeŋunaha siwo me nàte ŋu aɖo kadodo me kple ame bubu siwo le nu ma ke me tom abe wò ene ŋu. Nuteƒekpɔkpɔwo gbɔgblɔ kple kpekpeɖeŋu xɔxɔ tso ame bubuwo gbɔ xɔ asi ŋutɔ le ɣeyiɣi sia me.
• Di ɣeyiɣi na ɖokuiwò (Ðokuidzikpɔkpɔ): Kansa nye nɔnɔme si tea ɖeɖi ame ŋu. Ðokuidzikpɔkpɔ le vevie ŋutɔ ne wole agbe kple PTCL. Ƒo nu kple wò lãmesẽnyawo gbɔ kpɔha tso mɔ siwo dzi nàto akpɔ nuteɖeamedzi gbɔ (ŋugbledede, gbɔgbɔtsixe ƒe kamedede, modzakaɖeɖe aɖe me nɔnɔ), kple alesi nàwɔ nuɖuɖu si me nunyiame le si ana ŋusẽ nanɔ ŋuwò le atikewɔwɔa katã me ŋu. Dɔ alɔ̃ nyuie.

Nya kawoe wòle be mabia nye ɖɔkta?

Mègaŋlɔ be be yeabia nya siawo ne èkpɔ wò ɖɔkta o:

• Peripheral T-cell lymphoma ƒomevi kae le ŋunye? Nukae woyɔna?
• Afikae nye dɔlélea le? Afikae wòkaka ɖo?
• Atikewɔwɔmɔnu kawoe le asinye? Viɖe kple kuxi kawoe le atikewɔwɔ ɖesiaɖe ŋu?
• Dzidzedze ka ƒomevie woate ŋu akpɔ mɔ na tso atikewɔwɔ siawo me?
• Nukawoe nye atikewɔwɔ ƒe nugbegblẽ le ame ŋu? Aleke woate ŋu akpɔ wo gbɔe?
• Ðe wòle be mabu atikewɔwɔ yeye si wotu ɖe numekuku dzi (`(dɔdamɔnu dodokpɔ)`) ŋua? Ðe wosɔ nam?
• Tɔtrɔ kawoe wòle be mawɔ le nye agbenɔnɔ me?

Gbedasi Mamlɛtɔ si Wotsɔ Yi Aƒeme

Peripheral T-cell lymphoma (PTCL) nye ʋumenugbagbeviɣidɔ ƒomevi aɖe si mebɔ o gake wòle vevie. Edzɔna ne T-lãmenugbagbevi siwo kpɔa míaƒe ŋutilã ta la trɔ hezu kansa. Togbɔ be nu ɖeka si gbɔ wotso hã la, wo dometɔ ɖesiaɖe ƒe domenyiŋusẽfianu to vovo. Esi wònye be PTCL gblẽa nu le ŋutilã ƒe akpa vovovowo ŋu ta la, ate ŋu asesẽ ɣeaɖewoɣi be woakpɔ dɔlélea ahadae.

Gake, nɔ mɔkpɔkpɔ me! Atikewɔwɔ ŋuti numekulawo le atike yeye siwo wɔa dɔ wu dim ɣesiaɣi, siwo ku ɖe domenyiŋusẽfianu ƒe tɔtrɔ siwo le PTCL me ŋu. Ne wokpɔe be PTCL le ŋuwò la, mègatsi dzodzodzoe o, eye nàƒo nu kple wò atikewɔlawo ƒe ƒuƒoƒoa gaglãa . Bia nenye be atikewɔwɔ yeye siwo wotu ɖe numekuku dzi (dɔdamɔnu dodokpɔwo) li siwo sɔ na wò nɔnɔme tɔxɛa hã. Ne nyatakaka siwo sɔ kple wò lɔlɔ̃tɔwo kpe ɖe ŋuwò la, ŋusẽ asu asiwò be nàdze ŋgɔ kuxi sia!

` Peripheral T-cell Lymphoma, PTCL, Lymphoma, T-cell lymphoma, Kansa, Ʋu me kansa, Lãmetsiŋusẽ, PTCL ƒe dzesiwo, PTCL dɔdamɔnu